Chargement en cours...
Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D
This study examines the insurance coverage and out-of-pocket costs to Medicare beneficiaries for the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan.
Enregistré dans:
| Publié dans: | JAMA Cardiol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Medical Association
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6624798/ https://ncbi.nlm.nih.gov/pubmed/31290933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.2223 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|